4.6 Article

Venous Thromboembolism A Public Health Concern

Journal

AMERICAN JOURNAL OF PREVENTIVE MEDICINE
Volume 38, Issue 4, Pages S495-S501

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amepre.2009.12.017

Keywords

-

Funding

  1. Eisai
  2. GlaxoSmithKline

Ask authors/readers for more resources

Venous thromboembolism (VTE), defined as deep vein thrombosis, pulmonary embolism, or both, affects an estimated 300,000-600,000 individuals in the U.S. each year, causing considerable morbidity and mortality. It is a disorder that can occur in all races and ethmaties, all age groups, and both genders. With many of the known risk factors-advanced age, immobility, surgery, obesity-Increasing in society, VTE is an important and growing public health problem. Recently, a marked increase has occurred in federal and national efforts to raise awareness and acknowledge the need for VTE prevention. Yet, many basic public health functions-surveillance, research, and awareness are still needed. Learning and understanding more about the burden and causes of VTE, and raising awareness among the public and healthcare providers through a comprehensive public health approach, has enormous potential to prevent and reduce death and morbidity from deep vein thrombosis and pulmonary embolism throughout the U.S (Am J Prey Med 2010,38(4S).S495-S501) Published by Elsevier Inc on behalf of American Journal of Preventive Medicine

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available